MedTrace Logo

Nicotine Patch as an Adjunctive Intervention to Reduce Secondhand Smoke Among NICU Families

NCT04045964 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2024-12-11

Study results available
· View outcomes & findings →

Summary

The purpose of this study was to explore the potential for directly targeting smoking cessation, regardless of motivation level, in a subsample of neonatal intensive care unit (NICU) parents with the ultimate goal of reducing secondhand smoke (SHS) in their homes.

Conditions

  • Environmental Tobacco Smoke
  • Smoking Cessation

Interventions

DRUG

nicotine replacement therapy (NRT)

Participants were provided with either 2 weeks of 14-mg or 21-mg transdermal nicotine patches for every smoker in the home

BEHAVIORAL

motivational advice

Received two in-hospital motivational advice sessions by a research associate (RA). The RA adapted session content from a previous tobacco-smoke exposure protocol

BEHAVIORAL

Quitline referral

Quitline participants received information about tobacco-smoke exposure reduction and a referral to a tobacco Quitline.

Sponsors & Collaborators

  • The University of Texas Health Science Center, Houston

    lead OTHER

Principal Investigators

  • Angela L Stotts, PhD · The University of Texas Health Science Center, Houston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-10-29
Primary Completion
2018-06-28
Completion
2018-06-28
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04045964 on ClinicalTrials.gov